Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders

Functional gastrointestinal disorders (FGIDs) and IBDs are two of the most prevalent disorders of the GI tract and consume a significant proportion of healthcare resources. Recent studies have shown that membrane-bound guanylate cyclase-C (GC-C) receptors lining the GI tract may serve as novel thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Waldman, Scott A, Camilleri, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Recent Advances in Clinical Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204952/
https://www.ncbi.nlm.nih.gov/pubmed/29563144
http://dx.doi.org/10.1136/gutjnl-2018-316029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204952/
https://www.ncbi.nlm.nih.gov/pubmed/29563144
http://dx.doi.org/10.1136/gutjnl-2018-316029

Ejemplares similares